Is 6mg of Melatonin Too Much? What Experts Say

Six milligrams of melatonin is not dangerous for most adults, but it is almost certainly more than you need. A large dose-response analysis of randomized trials found that melatonin’s sleep-promoting effects peak at around 4 mg per day, with no additional benefit from going higher.¹ A separate review of long-term safety data concluded that doses of roughly 5 to 6 mg daily or less appear safe, though researchers widely agree the long-term picture is still incomplete.² So 6 mg sits at the upper boundary of what the evidence currently considers reasonable, and for most people, a smaller dose taken at the right time would work just as well.

Where the Sleep Benefits Actually Peak

The most common melatonin doses on store shelves range from 1 mg to 10 mg, with 5 mg and 10 mg gummies dominating sales. But more is not better here. When researchers pooled data from randomized controlled trials and ran a dose-response analysis, melatonin gradually shortened the time it takes to fall asleep and increased total sleep time up to about 4 mg per day. Beyond that threshold, the curve flattened.¹ Taking 6 mg, 8 mg, or 10 mg did not meaningfully improve sleep onset or duration compared to 4 mg.

For older adults specifically, the advice is even more conservative. A systematic review of dosing in people over 55 recommended using the lowest possible dose of an immediate-release formulation to mimic the body’s natural melatonin rhythm and avoid prolonged blood levels far above what the brain normally sees.³ Your body naturally produces melatonin in tiny amounts, peaking somewhere around 60 to 70 picograms per milliliter of blood in healthy young adults and less than that as you age. Even a 0.5 mg supplement can push blood levels well above that natural peak, which is why the doses sold commercially are sometimes described as pharmacological rather than physiological.

Why Timing Matters More Than You Think

One of the most underappreciated findings in the melatonin literature is that when you take it matters at least as much as how much you take. A study comparing the circadian phase-shifting ability of 0.5 mg versus 3.0 mg found that when each dose was given at its optimal time, both produced similarly sized shifts in the body clock.⁴ In other words, the smaller dose worked just as well for resetting your internal clock, provided you took it at the right moment. The optimal timing window simply shifted a bit later for the lower dose.

Melatonin acts as a timing signal for the brain’s internal clock, concentrated in a tiny structure called the suprachiasmatic nucleus. When taken around dusk, it pushes the clock earlier, which helps if you are trying to fall asleep sooner. When taken around dawn, it can push it later.⁵ The dose-response meta-analysis found that taking melatonin about three hours before your desired bedtime, rather than the more common practice of taking it 30 minutes before lights-out, improved its sleep-promoting effects.¹ Mathematical models of melatonin’s phase-shifting effects confirm this general pattern and suggest that careful timing can compensate for a smaller dose.⁶

This is the piece most people miss. If you are taking 6 mg right before bed and it doesn’t seem to be working well, the solution is less likely to be a higher dose and more likely to be an earlier dose. The sleep researchers who have studied this extensively note that melatonin’s benefits come primarily from correcting circadian phase problems and from a modest direct drowsiness effect, not from sedation the way a sleeping pill works.⁷ Doubling up on dose cannot substitute for getting the timing right.

What Happens Inside Your Body at 6 mg

One reason high doses of melatonin don’t produce proportionally better sleep is the way the body handles the molecule. Melatonin taken by mouth has surprisingly low bioavailability, ranging from about 9% to 33%.⁸ The liver breaks down most of it during its first pass through the digestive system. What does reach the bloodstream peaks quickly, generally within about an hour and a half, and clears fast, with a half-life of roughly one to two hours for an immediate-release form.⁹

At higher doses, the relationship between dose and blood levels stays roughly linear. In one pharmacokinetic study of older adults, a tenfold increase in dose produced approximately a tenfold increase in the area under the concentration curve.⁹ That means at 6 mg you are flooding your receptors with blood concentrations far above anything your pineal gland would ever produce. Whether those supra-physiological levels do anything useful for sleep beyond what a smaller dose achieves is exactly the question the dose-response data answers: past about 4 mg, they don’t.

Immediate-Release Versus Sustained-Release Formulations

The formulation you buy affects how 6 mg actually behaves in your system. A crossover study comparing sustained-release and immediate-release capsules found dramatic differences. The immediate-release form spiked blood levels to about twice as high, reaching its peak concentration faster. The sustained-release form produced a lower, broader curve, with blood levels staying elevated for longer, particularly during the four-to-eight hour window after taking it.¹⁰ The sustained-release version maintained concentrations one-and-a-half to three times higher than immediate-release during those later hours.

This distinction matters. If your problem is falling asleep, an immediate-release formulation at a lower dose may be all you need, since the sharp spike mimics the body’s natural onset of melatonin. If your problem is staying asleep through the night, a sustained-release product could help maintain levels during the second half of the night. But taking a high dose of immediate-release melatonin is a blunt workaround for a staying-asleep problem: you get a massive initial spike that is gone within a few hours anyway. Matching the formulation to your specific sleep complaint is a smarter lever to pull than just increasing the milligrams.

Side Effects at Various Doses

Melatonin has a remarkably clean safety record compared to conventional sleep medications. A systematic review covering 37 randomized trials that used doses ranging from 0.15 mg to 12 mg found that the most common side effects were daytime sleepiness (reported by under 2% of participants), headache, dizziness, and mild drops in body temperature, each occurring in less than 1% of users.¹¹ Serious side effects were rare and included agitation, mood changes, nightmares, and palpitations. Most side effects resolved on their own within a few days or disappeared immediately when melatonin was stopped.

A pharmacovigilance study using the World Health Organization’s global adverse-event database flagged a few signals worth knowing about. Nightmares and abnormal dreams were reported at rates roughly four to five times higher than with other drugs overall, though these signals disappeared when melatonin was compared specifically to other sleep medications.¹² Accidents, injuries, and falls also showed up as signals when compared to all drugs in the database, though again, those signals were not unique to melatonin compared to the sleep-medication class.

In clinical trials specifically examining higher doses for a sleep-related movement disorder (REM sleep behavior disorder), patients taking 9 mg or more reported headache and morning sedation, but those symptoms went away when the dose was reduced.¹³ At 3 mg, no adverse events were reported in those same trials. So while 6 mg is unlikely to cause you serious harm, you are closer to the zone where nuisance side effects like grogginess and headache become more likely.

No Evidence of Tolerance or Rebound

A common worry with any sleep aid is whether you will need progressively higher doses over time or whether your sleep will get worse once you stop. The evidence on melatonin is reassuring on both counts. A long-term open-label study found no tolerance to prolonged-release melatonin, and when patients stopped taking it, there was no rebound insomnia. In fact, the study noted a lingering benefit after discontinuation.¹⁴ A separate randomized trial in insomnia patients over 55 that specifically looked for rebound insomnia during a withdrawal phase found no sign of it.¹⁵ That stands in sharp contrast to prescription sleep drugs like benzodiazepines and Z-drugs, where worsening insomnia after stopping is a well-documented problem.¹⁶

A related concern is whether supplemental melatonin might suppress your body’s own production over time, similar to how taking exogenous hormones can sometimes shut down natural output. The available evidence says no. A study following patients on prolonged-release melatonin found that endogenous melatonin production, measured by a urinary metabolite, remained intact after long-term use and continued after the supplement was discontinued.¹⁴ An earlier study in shift workers given melatonin for a week, and a separate case involving a much higher daily dose given for over a month, both found the amplitude of endogenous melatonin secretion was unchanged by treatment.¹⁷ Your pineal gland appears to keep doing its job regardless of how much supplemental melatonin you throw at it.

The Label Accuracy Problem

Here is something that genuinely changes how you should think about dosing: what the bottle says and what you are actually swallowing may have little in common. A 2023 analysis of melatonin gummies sold in the U.S. found that the actual melatonin content ranged from 74% to 347% of what the label declared. Out of 25 products tested, only three were within 10% of the stated dose.¹⁸ An earlier study of melatonin supplements found even wilder variation: content ranged from 83% less to 478% more than labeled, and lot-to-lot variability within a single brand ran as high as 465%.¹⁹

This means your “6 mg” gummy might actually contain anywhere from about 4 mg to over 20 mg, depending on the brand and the lot. If you are experiencing inconsistent effects or unexpected side effects, the supplement itself could be the variable, not your body’s response. In the U.S., melatonin is regulated as a dietary supplement, not a drug, which means manufacturers face far less rigorous quality testing than they would for a prescription medication. If precise dosing matters to you, choosing a product that has been third-party tested by an independent lab (look for USP or NSF certification on the label) is one way to reduce this uncertainty.

When Doctors Actually Prescribe Higher Doses

Although 6 mg is more than most people need for ordinary insomnia, there are clinical situations where doctors intentionally use doses in that range or higher. REM sleep behavior disorder, a condition where people physically act out their dreams (sometimes violently), is one of the better-studied examples. In prospective trials, patients were given melatonin at 3, 6, or 9 mg depending on symptom severity, with some studies using doses up to 12 mg. The mean dose in one trial that enrolled patients who had failed other treatments was about 7 mg nightly.¹³ Side effects at those doses were minimal, limited to a small number of patients at 9 mg or above experiencing headache and morning sleepiness.

Researchers have also explored melatonin’s potential beyond sleep. It concentrates in mitochondria at levels much higher than in the bloodstream and may function as an antioxidant in those structures.²⁰ Some ongoing research involves doses well above 6 mg for conditions unrelated to sleep, including neurodegenerative disease. But these are investigational uses supervised by clinicians, not a justification for self-prescribing high doses at home.

Melatonin Safety in Children

If your household has melatonin gummies, the pediatric safety picture deserves attention. Melatonin is now the leading cause of unsupervised medication exposure and overdose in emergency departments for children aged six and under.²¹ A CDC report found that pediatric melatonin ingestion reports to poison control increased 530% over a ten-year period ending in 2021. Hospitalizations rose sharply, driven mainly by accidental ingestion in young children. Five children in the dataset required mechanical ventilation, and two died.²²

The combination of candy-like gummy formulations, the perception that melatonin is harmless because it is “natural,” and the label-accuracy problems described earlier creates real risk. A child eating several gummies from a bottle whose actual melatonin content is three or four times the label claim could be ingesting an enormous dose. Keeping melatonin out of children’s reach, ideally in a child-resistant container rather than the easy-open bags many gummies come in, is a straightforward precaution that too few households take.

A Practical Approach to Adjusting Your Dose

If you are currently taking 6 mg and sleeping fine with no grogginess in the morning, there is no urgent medical reason to change. But the evidence suggests you could almost certainly get the same benefit from less. A reasonable strategy is to step down by 1 mg at a time, holding each new dose for a week or two, until you find the lowest amount that still helps. Given that blood levels scale linearly with dose and the sleep benefits plateau well below 6 mg, most people can settle in the 1 to 3 mg range with no loss of effect, especially if they also shift their timing earlier, to around two to three hours before their intended bedtime.

Pay attention to the formulation too. If your 6 mg product is immediate-release and you have trouble staying asleep but fall asleep fine, switching to a sustained-release formulation at a lower total dose might address the real problem.¹⁰ And if you have been taking melatonin for months and are worried about dependency, the evidence is clear that stopping does not cause rebound insomnia or blunt your body’s own melatonin production. You can experiment without fear of making things worse.

1
PubMed. Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis
2
PubMed Central. Chronic Administration of Melatonin: Physiological and Clinical Considerations
3
PubMed. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature
4
The Journal of Clinical Endocrinology & Metabolism. Human Phase Response Curves to Three Days of Daily Melatonin: 0.5 mg Versus 3.0 mg
5
PubMed. Melatonin as a chronobiotic
6
PubMed Central. A mathematical model of the circadian phase-shifting effects of exogenous melatonin
7
Oxford Academic. Sleep-Promoting Effects of Melatonin: At What Dose, in Whom, Under What Conditions, and by What Mechanisms?
8
PubMed. Clinical pharmacokinetics of melatonin: a systematic review
9
PubMed Central. Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults
10
PubMed Central. Comparative Pharmacokinetics of Sustained-Release versus Immediate-Release Melatonin Capsules in Fasting Healthy Adults: A Randomized, Open-Label, Cross-Over Study
11
PubMed. Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review
12
PubMed. Investigating the safety profiles of exogenous melatonin and associated adverse events: A pharmacovigilance study using WHO-VigiBase
13
PubMed Central. Melatonin Therapy for REM Sleep Behavior Disorder: A Critical Review of Evidence
14
PubMed Central. Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal
15
PubMed. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects
16
PubMed Central. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults
17
PubMed. The amplitude of endogenous melatonin production is not affected by melatonin treatment in humans
18
JAMA. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US
19
PubMed Central. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content
20
PubMed Central. Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas
21
PubMed Central. Melatonin Use in Young Children: A Systematic Review
22
PubMed Central. Pediatric Melatonin Ingestions – United States, 2012-2021